Revolutionising Head and Neck Cancer Care: The EVEREST-HN Project
Oracle HNCUK is thrilled to support the innovative EVEREST-HN project, a game-changing study led by The Royal Marsden. Now entering its feasibility trial phase, this groundbreaking research is set to transform the way suspected head and neck cancer cases are identified and referred.
At the heart of the project is the development of a symptom-based risk stratification tool—a cutting-edge approach designed to streamline referrals and guide diagnostic decisions.
Why is this study important?
The EVEREST-HN trial could reshape the patient treatment journey by:
- Quickly identifying high-risk patients, ensuring timely access to vital investigations and care.
- Reducing unnecessary diagnostics for low-risk patients, improving efficiency and resource use.
- Transforming treatment pathways to enhance outcomes and improve quality of life for patients and their families.
This is more than just research—it’s a bold step towards a future where every patient gets the right care at the right time.
Get Involved
Is your centre ready to be part of this cutting-edge trial? Join us in shaping the future of head and neck cancer care.
Learn more about the EVEREST-HN project and how to participate: https://www.royalmarsden.nhs.uk/everest-hn/about-everest-hn
Together, we can make a real difference.
Data from the National Disease Registration Service on HPV associated and HPV independent oropharyngeal squamous cell carcinoma
The Get Data Out Programme from the National Disease Registration Service (NDRS), part of NHS England, has published statistics on incidence, routes to diagnosis and treatment for patients diagnosed with…
Join Us for an Evening of Research, Impact, and Conversation
Research & Impact EveningDate: Monday 28th April 2025Time: 6:00 PM – 8:30 PMVenue: Skyline, Tower Suites, 100 Minories, London EC3N 1JY A Celebration of Research Join us for a meaningful…
What the Rare Cancers Bill Means for Head & Neck Cancer
14 March marked a crucial moment for research into rare cancers, as the Rare Cancers Bill took another significant step toward becoming law! Dr. Scott Arthur, a Labour MP, introduced…
Theatre Meets Healthcare: Breaking Barriers in Cancer Conversations
In Leicester, theatre is transforming how Black communities talk about cancer. Oracle Head & Neck Cancer UK, alongside Theatre Sans Frontières, is using interactive Forum Theatre to tackle stigma, improve healthcare conversations, and break…
Jamie Theakston Announces He is Cancer-Free After Laryngeal Cancer Treatment
Heart Breakfast’s much-loved presenter, Jamie Theakston, has shared the incredible news that he is now cancer free! After completing treatment for stage one laryngeal cancer – cancer of the voice…
Mark Steele – Unforgettable evening of humour, resilience, and personal storytelling.
British comedian Mark Steele and military leader Major General Julian Buczacki are joining forces for an unforgettable evening of humour.
Research Large Grants Programme Opportunity
We’re offering up to £300,000 over three years to support innovative, hypothesis-driven research projects.
12 Days of Christmas Winter Appeal 2024
Counting down 12 days of Christmas with fundraising ideas and keeping in touch with Oracle.
Help Beat Head and Neck Cancer
Oracle Head & Neck Cancer UK is a registered charity in England and Wales (1142037), and in Scotland (SC052790).
Registered as a company limited by guarantee in England and Wales (7125497). Registered address: 80 Coombe Road, New Malden KT3 4QS.